$2.83 EPS Expected for Becton, Dickinson and Company (NYSE:BDX) This Quarter

Wall Street brokerages predict that Becton, Dickinson and Company (NYSE:BDX) will report earnings of $2.83 per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Becton, Dickinson and’s earnings, with estimates ranging from $2.59 to $2.97. Becton, Dickinson and posted earnings per share of $4.55 in the same quarter last year, which would indicate a negative year-over-year growth rate of 37.8%. The company is expected to report its next quarterly earnings results on Thursday, February 3rd.

According to Zacks, analysts expect that Becton, Dickinson and will report full year earnings of $12.41 per share for the current fiscal year, with EPS estimates ranging from $12.35 to $12.46. For the next financial year, analysts forecast that the firm will report earnings of $13.64 per share, with EPS estimates ranging from $13.43 to $13.89. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Becton, Dickinson and.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, November 4th. The medical instruments supplier reported $2.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.45 by $0.14. The firm had revenue of $5.10 billion during the quarter, compared to the consensus estimate of $4.91 billion. Becton, Dickinson and had a return on equity of 15.97% and a net margin of 10.22%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.79 EPS.

A number of analysts have recently commented on BDX shares. SVB Leerink restated a “market perform” rating on shares of Becton, Dickinson and in a report on Friday, October 22nd. JPMorgan Chase & Co. lowered Becton, Dickinson and from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $276.93 to $265.00 in a report on Friday, August 6th. Finally, Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $250.00 target price on the stock in a report on Tuesday, October 19th. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $271.00.

In other Becton, Dickinson and news, EVP James C. Lim sold 6,956 shares of the company’s stock in a transaction on Friday, September 3rd. The stock was sold at an average price of $257.44, for a total transaction of $1,790,752.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rebecca W. Rimel sold 500 shares of the company’s stock in a transaction on Wednesday, September 8th. The stock was sold at an average price of $260.00, for a total value of $130,000.00. Following the sale, the director now owns 3,586 shares of the company’s stock, valued at $932,360. The disclosure for this sale can be found here. Insiders have sold 8,174 shares of company stock worth $2,104,313 in the last three months. 0.76% of the stock is currently owned by company insiders.

Institutional investors have recently modified their holdings of the business. Ameritas Investment Company LLC acquired a new stake in shares of Becton, Dickinson and in the 1st quarter valued at about $39,000. Tudor Investment Corp Et Al acquired a new stake in shares of Becton, Dickinson and in the 1st quarter valued at about $4,247,000. Merit Financial Group LLC acquired a new stake in shares of Becton, Dickinson and in the 1st quarter valued at about $273,000. BSW Wealth Partners bought a new position in Becton, Dickinson and in the 1st quarter valued at about $392,000. Finally, Verition Fund Management LLC bought a new position in Becton, Dickinson and in the 1st quarter valued at about $306,000. Hedge funds and other institutional investors own 84.25% of the company’s stock.

Shares of Becton, Dickinson and stock traded down $2.12 during trading on Thursday, reaching $244.46. 911,617 shares of the company were exchanged, compared to its average volume of 1,358,593. Becton, Dickinson and has a twelve month low of $226.15 and a twelve month high of $267.37. The company has a quick ratio of 0.90, a current ratio of 1.33 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $70.21 billion, a price-to-earnings ratio of 35.69, a P/E/G ratio of 2.73 and a beta of 0.70. The business has a 50-day moving average price of $246.23 and a 200-day moving average price of $246.88.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 31st. Investors of record on Friday, December 10th will be given a dividend of $0.87 per share. The ex-dividend date of this dividend is Thursday, December 9th. This represents a $3.48 dividend on an annualized basis and a yield of 1.42%. This is an increase from Becton, Dickinson and’s previous quarterly dividend of $0.83. Becton, Dickinson and’s dividend payout ratio is currently 48.47%.

Becton, Dickinson and announced that its Board of Directors has initiated a share buyback program on Thursday, November 4th that authorizes the company to buyback 10,000,000 outstanding shares. This buyback authorization authorizes the medical instruments supplier to reacquire shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

About Becton, Dickinson and

Becton, Dickinson & Co is a medical technology company. The firm engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

Featured Article: Consumer Price Index (CPI)

Get a free copy of the Zacks research report on Becton, Dickinson and (BDX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.